All Insights
Showing 1 - 12 of 409
Life Sciences and Healthcare
EU pharma package widens the Bolar exemption and moves the line on patent infringement
Pricing and reimbursement procedures, tender bids and third-party suppliers will fall outside patent infringement. Originators lose an important hook for
Life Sciences and Healthcare
Licences in Insolvency: German Law, the New EU Directive, and What Licensors and Licensees Must Do Now
Germany's long-standing failure to legislate on the treatment of licences in insolvency is not merely a technical legal problem. It
Regulatory Outlook
Products | UK Regulatory Outlook October 2026
General/digital products updates: UK: Law Commission launches consultation on product liability reform | Private member's bill would introduce mandatory safety
Competition, antitrust and trade
The French Competition Authority imposes a penalty on a merger below the thresholds under the rules on anti-competitive practices
Following on from the CJEU's Towercast judgment, the French Competition Authority (FCA) has, for the first time in France, imposed
Regulatory Outlook
Products | UK Regulatory Outlook September 2026
General/digital products: UK updates: Tobacco and vapes: retail licensing, packaging and age of sale update | OPSS publishes guidance on
Life Sciences and Healthcare
UK life sciences head into autumn as policy and regulatory reforms race to match tech advances
MHRA progresses on AI, gene therapy and medicines regulation as the UK positions itself as a global sector leader
Regulatory and compliance
EU clamps down on meat names for plant-based and cultivated alternatives
New rules for the use of meat terms will force plant-based and cultivated producers to rebrand ahead of a 2029
Life Sciences and Healthcare
English High Court grants dynamic website blocking order to tackle counterfeit medicines
Creative solution to IP and regulatory breaches gives life sciences companies greater control over unlawful online sales
Life Sciences and Healthcare
European courts and regulators target the intersection of regulatory and patent trends in the life sciences
The Tecfidera case and provisional pharma reform agreement put regulatory exclusivity and patent protection in focus
Life Sciences and Healthcare
EU pharma regulators publish annual AI observatory report
The EMA and HMA signal a shift from AI adoption to implementation, with coordinated AI pharma guidance underway
Life Sciences and Healthcare
CJEU judgment redraws the perimeter of EU medical device rules
Ruling on unprinted patient wristbands tightens qualification, marketing claims and distributor duties
